Carmen Andreescu, CarmenMulsant, Benoit H.Rothschild, Anthony J.Flint, Alastair J.Meyers, Barnett S.Whyte, Ellen M.2022-08-232022-08-232006-01-012010-05-13Andreescu C, Mulsant BH, Rothschild AJ, Flint AJ, Meyers BS: Pharmacotherapy of Major Depression with Psychotic Features – What is the Evidence? Psych Annals, 2006; 36:31-38.https://hdl.handle.net/20.500.14038/46398Major depression with psychotic features (MD-Psy) is a significant public health problem. In American studies, between 15% (community sample, ECA) and 25% (inpatient sample) of mixed-age patients who meet criteria for major depressive disorder present with psychotic features. Similarly, in a large European epidemiological study, 19% of noninstitutionalized people ages 19 to 100 with major depression had psychotic features. Among geriatric patients who require hospitalization for the treatment of their depression, the prevalence of MD-Psy may reach 45%. Compared with patients with nonpsychotic depression, patients with MD-Psy exhibit greater impairment following resolution of the depressive episode, greater risk of relapse and recurrence, increased number of suicide attempts, prolonged hospitalizations, increased comorbidity, and increased financial dependence.en-USDepressive Disorder, MajorAffective Disorders, PsychoticPsychiatryJournal Articlehttps://escholarship.umassmed.edu/psych_pp/991310024psych_pp/99